All images in this section are for illustration purposes only. Not actual patients or caregivers.

All images in this section are for illustration purposes only. Not actual patients or caregivers.

Chronic Sialorrhea in Pediatrics

XEOMIN Is the First and Only FDA-Approved Neuromodulator
For Pediatric Patients With Chronic Sialorrhea

blue background Closeup of pediatric chin and neck area

The most common cause of sialorrhea is a nerve and muscle condition, but it can also be caused by problems with brain signaling, muscular problems, or excessive secretion of saliva.1

blue background Injection into pediatric submandibular gland

XEOMIN blocks certain chemicals at the point where salivary glands and nerves meet. It slows down the release of the chemicals at the nerve endings that promote saliva production.2

Images are for illustration purposes only. Individual results may vary.

XEOMIN Helps Improve Chronic Sialorrhea Symptoms

In clinical studies, pediatric patients had significant and sustained reduction in saliva over 16 weeks.2

Does this seem familiar?

Emma and Jacob* are children
with chronic sialorrhea

*Images and fictionalized stories are for illustration
purposes only. Not actual patients.

References

  1. Hockstein NG, Samadi DS, Gendron K, Handler SD. Sialorrhea: a management challenge. Am Fam Physician. 2004;69(11):2628-2634. http://www.aafp.org/afp/2004/0601/p2628.html. Accessed June 18, 2021.
  2. XEOMIN® [Package insert]. Raleigh, NC: Merz Pharmaceuticals, LLC; 2021.